Biontech Se Stock Market Value
| BNTX Stock | USD 102.14 4.26 4.00% |
| Symbol | BioNTech |
BioNTech SE Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioNTech. If investors know BioNTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioNTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.227 | Earnings Share (2.05) | Revenue Per Share 12.618 | Quarterly Revenue Growth 0.39 | Return On Assets (0.01) |
The market value of BioNTech SE is measured differently than its book value, which is the value of BioNTech that is recorded on the company's balance sheet. Investors also form their own opinion of BioNTech's value that differs from its market value or its book value, called intrinsic value, which is BioNTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioNTech's market value can be influenced by many factors that don't directly affect BioNTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioNTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioNTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioNTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
BioNTech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioNTech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioNTech.
| 09/22/2024 |
| 11/21/2024 |
If you would invest 0.00 in BioNTech on September 22, 2024 and sell it all today you would earn a total of 0.00 from holding BioNTech SE or generate 0.0% return on investment in BioNTech over 60 days. BioNTech is related to or competes with Agilent Technologies, Equillium, and 23Andme Holding. BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseas... More
BioNTech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioNTech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioNTech SE upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.61 | |||
| Information Ratio | 0.0512 | |||
| Maximum Drawdown | 24.81 | |||
| Value At Risk | (3.90) | |||
| Potential Upside | 4.85 |
BioNTech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioNTech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioNTech's standard deviation. In reality, there are many statistical measures that can use BioNTech historical prices to predict the future BioNTech's volatility.| Risk Adjusted Performance | 0.0669 | |||
| Jensen Alpha | 0.1953 | |||
| Total Risk Alpha | (0.13) | |||
| Sortino Ratio | 0.0686 | |||
| Treynor Ratio | 0.3264 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of BioNTech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
BioNTech SE Backtested Returns
BioNTech appears to be very steady, given 3 months investment horizon. BioNTech SE secures Sharpe Ratio (or Efficiency) of 0.0821, which signifies that the company had a 0.0821% return per unit of risk over the last 3 months. We have found thirty technical indicators for BioNTech SE, which you can use to evaluate the volatility of the firm. Please makes use of BioNTech's Downside Deviation of 2.61, risk adjusted performance of 0.0669, and Mean Deviation of 2.11 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, BioNTech holds a performance score of 6. The firm shows a Beta (market volatility) of 0.81, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, BioNTech's returns are expected to increase less than the market. However, during the bear market, the loss of holding BioNTech is expected to be smaller as well. Please check BioNTech's maximum drawdown, as well as the relationship between the skewness and day typical price , to make a quick decision on whether BioNTech's price patterns will revert.
Auto-correlation | 0.51 |
Modest predictability
BioNTech SE has modest predictability. Overlapping area represents the amount of predictability between BioNTech time series from 22nd of September 2024 to 22nd of October 2024 and 22nd of October 2024 to 21st of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioNTech SE price movement. The serial correlation of 0.51 indicates that about 51.0% of current BioNTech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.51 | |
| Spearman Rank Test | 0.26 | |
| Residual Average | 0.0 | |
| Price Variance | 16.11 |
BioNTech SE lagged returns against current returns
Autocorrelation, which is BioNTech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BioNTech's stock expected returns. We can calculate the autocorrelation of BioNTech returns to help us make a trade decision. For example, suppose you find that BioNTech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
BioNTech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BioNTech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BioNTech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BioNTech stock over time.
Current vs Lagged Prices |
| Timeline |
BioNTech Lagged Returns
When evaluating BioNTech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BioNTech stock have on its future price. BioNTech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BioNTech autocorrelation shows the relationship between BioNTech stock current value and its past values and can show if there is a momentum factor associated with investing in BioNTech SE.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BioNTech Stock Analysis
When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.